Stock analysis · Bull Rankings model

UHS analysis

Universal Health Services, Inc.Medical Care Facilities. Scored on the same transparent 7-signal model behind the daily rankings.

UHS
Universal Health Services, Inc. · Medical Care Facilities
FCF$913mC+
Rev+9.7%B
D/E0.67C+
P/E6.4xA
PEG1.10B+
72.7Score
$153.77$9.3B
1Y Target$213.82Analyst consensus · 17 analysts
5Y Target$269.95Compound horizon
10Y Target$346.20Long-dated conviction
FCF$913mTTM
C+
FCF $913m — respectable but not differentiating
Rev+9.7%TTM YoY
B
Revenue +9.7% — at or above S&P median
D/E0.67
C+
D/E 0.67 — above the Healthcare debt median (≈75th pctile)
P/E6.4x
A
P/E 6.4 — cheapest decile in Healthcare (≈10th pctile)
PEG1.10
B+
PEG 1.10 — near fair value, classic Lynch benchmark (1.0)

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Quality-growth score · 72.7
Quality0.69
Growth0.66
Value0.84
Why this score
  • Buying back stock
Entry · Margin of safety
52-week rangeNear 52-week low
38% off the 12-month high
vs DCF fair value34% belowest. fair value ~$234
Quality signals · context only
ROIC13.3% · B+return on invested capital — not score-weighted
Why now
Medical Care Facilities · market cap $9.3b. Down 38% from 52-week high of $246.33 — deep drawdown territory. 17 sell-side analysts publish a mean 1-yr target of $213.82 (implying +39% upside).
Moat
ROE 20% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Down 38% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $213.82 (17-analyst consensus) — multiple re-rating thesis requires a catalyst. 5 yr $269.95 at ~12% CAGR — dividend + buyback compounding. 10 yr $346.20 if the moat survives secular pressure.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Trend
+0.1 over 14 daily scores
From 72.6 (Jun 22) → 72.7 (now)

One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.

Shares to buy
13
Position size
$1,999
4.0% of portfolio
Stop price
$115.33
25% below $153.77
$ at risk if stopped
$499.75
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Universal Health Services, Inc. (UHS): score, valuation & FAQ

Universal Health Services, Inc. (UHS) is a Medical Care Facilities company that scores 72.7 out of 100 on the Bull Rankings quality-growth model — a solid, above-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are P/E (A) and PEG (B+). On valuation, UHS sits about 34% below our discounted-cash-flow fair value (a margin of safety).

Is UHS a good stock to buy?

Bull Rankings scores UHS 72.7 out of 100 on its quality-growth model, which is a solid, above-average reading. That is driven by P/E (A) and PEG (B+). A score is a quantitative screen of Universal Health Services, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does UHS score 72.7 on Bull Rankings?

The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). UHS earns its highest marks on P/E (A) and PEG (B+). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.

Is UHS overvalued or undervalued?

Based on $153.77, UHS sits about 34% below our discounted-cash-flow fair value (a margin of safety). It trades at a 6.4x× P/E (graded A). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in UHS?

Down 38% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial adviser.

More Healthcare stocks by score

All Healthcare rankings →

Analyze another ticker →